Fisher Asset Management LLC Sells 469,613 Shares of Lam Research Corporation $LRCX

Fisher Asset Management LLC cut its holdings in Lam Research Corporation (NASDAQ:LRCX) by 51.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 449,510 shares of the semiconductor company’s stock after selling 469,613 shares during the period. Fisher Asset Management LLC’s holdings in Lam Research were worth $43,755,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Edgestream Partners L.P. increased its stake in Lam Research by 14.9% during the second quarter. Edgestream Partners L.P. now owns 4,789 shares of the semiconductor company’s stock worth $466,000 after acquiring an additional 621 shares during the last quarter. Panagora Asset Management Inc. boosted its holdings in shares of Lam Research by 1.4% in the 2nd quarter. Panagora Asset Management Inc. now owns 832,578 shares of the semiconductor company’s stock worth $81,043,000 after purchasing an additional 11,461 shares during the period. Virtus Advisers LLC bought a new position in shares of Lam Research during the 2nd quarter valued at approximately $292,000. VestGen Advisors LLC raised its holdings in Lam Research by 279.8% during the 2nd quarter. VestGen Advisors LLC now owns 18,332 shares of the semiconductor company’s stock valued at $1,784,000 after buying an additional 13,505 shares during the period. Finally, BLI Banque de Luxembourg Investments bought a new stake in Lam Research in the second quarter worth $4,247,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Trading Up 2.2%

Shares of NASDAQ LRCX opened at $158.19 on Wednesday. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $167.15. The business has a fifty day moving average price of $148.20 and a 200 day moving average price of $116.01. The stock has a market capitalization of $198.69 billion, a P/E ratio of 34.84, a price-to-earnings-growth ratio of 1.68 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the previous year, the company posted $0.86 earnings per share. The firm’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s dividend payout ratio is presently 22.91%.

Analyst Ratings Changes

A number of research analysts have weighed in on LRCX shares. Rothschild & Co Redburn boosted their price objective on shares of Lam Research from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. UBS Group reiterated a “buy” rating and set a $175.00 price target (up from $165.00) on shares of Lam Research in a report on Tuesday, November 25th. BNP Paribas Exane increased their price objective on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research report on Monday. Finally, Berenberg Bank increased their price target on Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.87.

Insider Activity

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 102,608 shares of company stock valued at $14,916,496 in the last ninety days. 0.31% of the stock is currently owned by insiders.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.